Sex differences in the course of schizophrenia across diverse regions of the world

por Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM
Publicado 2016

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients

por Novick D, Montgomery W, Aguado J, Peng XM, Haro JM
Publicado 2016

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study

por Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM
Publicado 2015

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

por Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H
Publicado 2014

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

por Novick D, Montgomery W, Haro JM, Moneta MV, Zhu G, Yue L, Hong J, Dueñas H, Brugnoli R
Publicado 2016

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline

por Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR
Publicado 2018